http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103285406-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140efb7e2a330be53d94bda6ad75cbe5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00dc6a0d0676332a358b84fb70505de3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76bf9ad3de6377c62c285259e768a146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2947e8d19ea71a43162ac4829422b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8be7fa742d74ca0352cb1a1ed547e3 |
| publicationDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103285406-B |
| titleOfInvention | MicroRNA-203, and application of analogue thereof in preparation of medicament for preventing and treating obesity, dyslipidemia and complication of obesity and dyslipidemia |
| abstract | The invention discloses microRNA-203, and application of an analogue of the microRNA-203 in preparation of a medicament for preventing and treating obesity, dyslipidemia and complication of the obesity and the dyslipidemia and belongs to the field of biological medicine. The prepared medicament disclosed by the invention can be miR-203 and a single ingredient of the analogue of the miR-203, and also can be a pharmaceutical composition. The pharmaceutical composition is prepared from effective dosage of miR-203 and/or analogue thereof and a pharmaceutical acceptable carrier in a mixing manner; the carrier can be cholesterol, virus, nano-particles, chitosan, lipidosome and the like; synthetic miR-203 and/or the analogue thereof are/is connected with the carrier to form the medicament. The medicament can be used for treating the obesity, the dyslipidemia or the complication of the obesity and the dyslipidemia by vein, muscle or intraperitoneal injection and the like. |
| priorityDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.